Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale CFO and Treasurer sold 50,000 shares at an average $61.89 ($3,094,563)
  2. 4 Open-market sale COO and Secretary sold 10,000 shares at an average $61.02 ($610,171)
  3. 4 Open-market sale Director sold 1,666 shares at an average $61.61 ($102,641)
  4. 4 Open-market sale Chief Medical Officer sold 7,092 shares at an average $66.38 ($470,741)
  5. 4 Open-market sale Director sold 100,000 shares at an average $66.22 ($6,622,207)
  6. 4 Open-market sale President and CEO sold 18,334 shares at an average $66.35 ($1,216,551)
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 10-K Report Annual Report
  9. 8-K Event Results of operations
  10. 4 Open-market sale CFO and Treasurer sold 50,000 shares at an average $65.09 ($3,254,710)
  11. 4 Open-market sale 10% owner sold 2,216,798 shares at $65.00 ($144,091,870)
  12. 4 Open-market sale Chief Medical Officer sold 3,156 shares at an average $70.33 ($221,972)
  13. 4 Open-market sale COO and Secretary sold 3,047 shares at an average $70.35 ($214,341)
  14. 4 Open-market sale CFO and Treasurer sold 3,035 shares at an average $70.34 ($213,480)
  15. 4 Open-market sale President and CEO sold 9,473 shares at an average $70.30 ($665,984)
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Other events
  20. 4 Open-market sale COO and Secretary sold 1,468 shares at an average $74.80 ($109,809)

Page 25 of 40 · 789 filings